MARKSANS.NS

Marksans Pharma Limited [MARKSANS.NS] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

MARKSANS.NS Stock Summary

Top 10 Correlated Stocks

MARKSANS.NS

In the News

MARKSANS.NS Financial details

Company Rating
-
Market Cap
73.8B
Income
3.17B
Revenue
21.03B
Book val./share
-
Cash/share
-
Dividend
0.5
Dividend %
0.31%
Employees
852
Optionable
No
Shortable
Yes
Earnings
28 May 2024
P/E
24.96
Forward P/E
-
PEG
4.23
P/S
3.7
P/B
3.95
P/C
-
P/FCF
-
Quick Ratio
3.37
Current Ratio
5.12
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
7.17
EPS next Y
-
EPS next Q
-
EPS this Y
42.13%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
26.61%
Revenue last 5Y
13.41%
Revenue Q/Q
10.33%
EPS Q/Q
-
-
-
-
-
SMA20
-0.46%
SMA50
-15.56%
SMA100
-35.61%
Inst Own
-
Inst Trans
-
ROA
13%
ROE
33%
ROC
0.2%
Gross Margin
51%
Oper. Margin
20%
Profit Margin
15%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
70.55-179.3
52W High
+22.56%
52W Low
+213.41%
RSI
54
Rel Volume
1.73
Avg Volume
1.27M
Volume
2.2M
Perf Week
2.46%
Perf Month
11.02%
Perf Quarter
-24.78%
Perf Half Y
-20.05%
-
-
-
-
Beta
1.596
-
-
Volatility
4.46%, 10.69%
Prev Close
0.03%
Price
219.39
Change
0.19%

MARKSANS.NS Financial Performance

MARKSANS.NS Dividend History

MARKSANS.NS Frequently Asked Questions

What is Marksans Pharma Limited stock symbol ?

Marksans Pharma Limited is a IN stock and trading under the symbol MARKSANS.NS

What is Marksans Pharma Limited stock quote today ?

Marksans Pharma Limited stock price is $219.39 today.

Is Marksans Pharma Limited stock public?

Yes, Marksans Pharma Limited is a publicly traded company.

Something similar

Top by Market Cap
BRK-B
AVGO
LLY
BRH.DE
ABEC.DE
Same Sector
CRW.L
HCAT
3360.T
HRTX
LBIRD.PA
Top Correlated Stocks
DATAMATICS.NS
STAR.NS
IPCALAB.NS
DECCANCE.NS
LT.NS
Similar Market Cap
UNA.AS
0J8P.L
SAF.PA
2492.T
6376.T

Company Profile

Healthcare Drug Manufacturers - General
  • Volume Average 1.27M
  • Market Capitalization 73.8B
  • Employee 852
  • CEO Mr. Mark B. Saldanha
  • Headquarters Mumbai,IN
  • IPO Date 2002-07-19
  • Website https://marksanspharma.com

Marksans Pharma Limited, together with its subsidiaries, engages in the research and development, manufacturing, marketing, distribution, and sale of generic pharmaceutical formulations worldwide. The company offers products in the analgesics, benign prostatic hyperplasia, antidiabetic, epilepsy, anti-inflammatory, hyperparathyroidism, diabetes, antacids, neurology, cardiovascular, hormonal, oncology, gastroenterology, antidiabetic, pain management, gynecology, antibiotic, antifungal, antiulceratives, vitamins, dermatology, cephalosporins, injectables, anti-allergy, antibacterial, and hypertension therapeutic areas. It also provides contract research and manufacturing services. Marksans Pharma Limited was incorporated in 1992 and is headquartered in Mumbai, India.